National Cancer Institute -Cairo University

Name

National Cancer Institute -Cairo University

Legal name

National Cancer Institute, Cairo University (المعهد القومي للأورام - جامعة القاهرة)

Website

https://nci.cu.edu.eg

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Oncology Healthcare Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Medical and Diagnostic Laboratories (62151), General Medical and Surgical Hospitals (622110)

SIC

Services-Hospitals (8060), Services-Medical Laboratories (8071), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

• Cancer treatment services
• Oncology diagnostics
• Radiation therapy
• Cancer research
• Graduate oncology education

Headquarters

HQ city

cairo

HQ country

Egypt

HQ region

Africa

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Distribution channels1 record

Marketing channels5 records

Core offering

The National Cancer Institute (NCI) - Cairo University is a public, non-profit academic medical institution that provides comprehensive cancer diagnosis and treatment—including surgery, chemotherapy, radiation therapy, diagnostic imaging, endoscopy, and palliative care—free of charge to all patients. It also conducts advanced cancer research (including Next-Generation Sequencing, electron microscopy, molecular biology, and tissue culture services) and offers postgraduate Master's and PhD programs in oncology specialties. The institute operates across three hospitals (Main Hospital at Foum El-Khalig, Breast Disease Hospital, and Outpatient Clinics) and an ISO 15189:2012-accredited Bone Marrow Transplantation Laboratory, serving approximately 25% of all new cancer cases in Egypt annually.

Product overview

The National Cancer Institute (NCI) - Cairo University is a comprehensive cancer center affiliated with Cairo University, offering integrated cancer care through its main hospital (فم الخليج), Breast Disease Hospital, and Outpatient Clinics. The institute provides treatment services (surgery, chemotherapy, radiation therapy), diagnostic services (radiology, pathology, endoscopy), and operates a specialized BMT Lab Unit accredited to ISO 15189:2012. NCI also hosts the Cancer Biology Department with state-of-the-art research laboratories offering Electron Microscopy, Viral Profiling, Next-Generation Sequencing, Tissue Culture, and Molecular Biology services. As an academic institution, NCI offers graduate education programs (Master's and PhD) across multiple oncology specialties and provides training programs for healthcare professionals. The institute serves approximately 25% of new cancer cases in Egypt annually, treating over 1,000 patients daily across approximately 40 specialized clinics.

Differentiator

Problem solved

Functional benefit

Brands

• BGO (Banquet of Goodness): Annual conference of the National Cancer Institute, Cairo University, held under the title 'One Voice and One Vision for a Cancer-Free Future'
• Green Office (المكتب الأخضر)
• Quality Assurance Unit (وحدة ضمان الجودة)
• Gate of Goodness Donation Portal (بوابة الخير للتبرعات)
• Drug Information Center (مركز المعلومات الدوائية)
• Awareness Committee (لجنة التوعية)

Products and services

• Cancer Treatment Services Comprehensive cancer treatment services for patients of all ages, including surgery (over 4,000 major and 2,500 minor operations annually), chemotherapy (over 1,040 sessions annually), radiation therapy (over 63,000 sessions annually), and palliative care provided free of charge across approximately 40 specialized clinics.
• Diagnostic Services Comprehensive diagnostic services for cancer patients including diagnostic imaging (over 60,000 procedures annually), clinical pathology, diagnostic endoscopy (over 5,000 procedures annually), and laboratory tests.
• BMT Lab Unit (Bone Marrow Transplantation Laboratory) Reference laboratory providing diagnostic tests for hemato-oncologic diseases and stem cell transplantation, accredited to ISO 15189:2012 since 2019 in flow cytometry, molecular gene tests, and Histocompatibility and Immunogenetics; also offers External Quality Assessment (EQA) services to clinical laboratories.
• Cancer Biology Department Research Services State-of-the-art research services including Electron Microscopy, Viral Profiling, Next-Generation Sequencing (whole genome, exome, transcriptome), Tissue Culture Lab (cancer cell lines), and Molecular Biology Lab (PCR, cloning, and protein expression) for cancer researchers and graduate students.
• Graduate Education Programs Master's and PhD programs in multiple oncology specialties including Surgical Oncology, Medical Oncology, Pediatric Oncology, Radiation Oncology, Clinical Pathology, Tumor Pathology, Cancer Epidemiology, Cancer Biology (Biochemistry, Pharmacology, Virology/Immunology), and Diagnostic Radiology.
• Hospitals (Main Hospital, Breast Hospital, Outpatient Clinics) Three hospital facilities—the Main Hospital (Foum El-Khalig), Breast Disease Hospital (First Settlement), and Outpatient Clinics—delivering specialized cancer care services to patients free of charge.
• Drug Information Center Pharmaceutical information and patient education center providing drug information services, lectures, newsletters, pharmacovigilance, and drug formulary management.
• Training Programs Professional training programs for healthcare professionals in cancer biology and research techniques.

Quantifiable outcome

• Handles 25% of all new cancer cases annually in Egypt
• +4 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Recent moves7 records

Expansion highlights3 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/NCI.eg
• LinkedInlinkedin.com/company/nci-egypt

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Cancer Institute -Cairo University